BridgeBio Pharma, Inc.
NASDAQ:BBIO
25.2 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2.168 | 211.12 | 1.745 | 4.091 | 1.641 | 1.826 | 1.87 | 0.338 | 73.746 | 1.694 | 12.886 | 2.344 | 54.024 | 0.462 | 0.122 | 8.127 | 0 | 0 | 13.819 | 26.741 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.872 | 1.894 | 0.598 | 0.598 | 0.599 | 0.651 | 0.647 | 0.739 | 0.7 | 1.348 | 1.551 | 1.454 | 0.109 | 0 | 0 | 0 | 0 | 0 | 0 | 2.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.296 | 209.226 | 1.147 | 3.493 | 1.042 | 1.175 | 1.223 | -0.401 | 73.046 | 0.346 | 11.335 | 0.89 | 53.915 | 0.462 | 0.122 | 8.127 | 0 | 0 | 13.819 | 24.241 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.137 | 0.991 | 0.657 | 0.854 | 0.635 | 0.643 | 0.654 | -1.186 | 0.991 | 0.204 | 0.88 | 0.38 | 0.998 | 1 | 1 | 1 | 0 | 0 | 1 | 0.907 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 114.695 | 140.972 | 130.226 | 125.136 | 108.087 | 93.512 | 91.549 | 92.511 | 108.4 | 107.649 | 123.751 | 104.305 | 102.069 | 122.559 | 90.174 | 92.05 | 86.598 | 68.225 | 57.485 | 55.278 | 52.331 | 44.853 | 51.202 | 31.148 | 23.892 | 33.831 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45.407 | 0 | 0 | 45.407 | 37.437 | 36.016 | 37.969 | 34.262 | 34.972 | 23.495 | 16.918 | 18.899 | 14.381 | 10.308 | 10.891 | 8.007 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.342 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 58.249 | 64.511 | 47.583 | 35.777 | 36.122 | 31.108 | 31.862 | 31.188 | 36.426 | 43.713 | 54.749 | 46.084 | 45.97 | 45.407 | 37.437 | 36.016 | 37.969 | 34.262 | 34.972 | 23.495 | 16.918 | 18.899 | 14.381 | 10.308 | 10.891 | 8.007 |
| Other Expenses
| 0.468 | 9.483 | 8.904 | 0.272 | 1.476 | -0.601 | 4.56 | 6.331 | 97.13 | -7.575 | 28.284 | -0.684 | 2.457 | 5.766 | 2.978 | 0.009 | -1.827 | 0.474 | -0.158 | -0.026 | -0.007 | -0.007 | 0.005 | 0.006 | -0.716 | -0.586 |
| Operating Expenses
| 172.944 | 205.483 | 177.809 | 161.185 | 144.209 | 124.62 | 123.411 | 123.699 | 144.826 | 151.362 | 178.5 | 150.389 | 148.039 | 167.966 | 127.611 | 128.066 | 124.567 | 102.487 | 92.457 | 78.773 | 69.249 | 63.752 | 65.583 | 41.456 | 34.783 | 41.838 |
| Operating Income
| -172.648 | 3.743 | -177.416 | -157.692 | -146.099 | -126.163 | -122.188 | -129.116 | 26.116 | -151.016 | -165.614 | -149.499 | -94.015 | -167.504 | -127.489 | -119.939 | -124.567 | -102.487 | -78.638 | -54.532 | -69.249 | -63.752 | -65.583 | -41.456 | -34.783 | -41.838 |
| Operating Income Ratio
| -79.635 | 0.018 | -101.671 | -38.546 | -89.03 | -69.093 | -65.341 | -382 | 0.354 | -89.148 | -12.852 | -63.779 | -1.74 | -362.563 | -1,044.992 | -14.758 | 0 | 0 | -5.691 | -2.039 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 97.104 | -39.903 | 21.024 | -19.307 | -2.055 | -16.569 | -18.382 | -11.077 | -28.675 | -50.314 | 28.284 | -0.684 | 2.457 | 5.766 | 2.978 | 0.009 | -1.827 | 0.474 | -4.883 | -6.755 | -4.737 | -6.12 | 16.048 | 0.006 | -0.716 | -0.586 |
| Income Before Tax
| -75.544 | -36.16 | -170.328 | -176.999 | -160.703 | -142.732 | -140.57 | -140.193 | -2.559 | -201.33 | -152.282 | -161.016 | -102.074 | -171.082 | -135.025 | -130.167 | -136.214 | -104.082 | -84.151 | -60.664 | -74.265 | -69.436 | -49.241 | -42.078 | -35.702 | -42.43 |
| Income Before Tax Ratio
| -34.845 | -0.171 | -97.609 | -43.265 | -97.93 | -78.166 | -75.171 | -414.772 | -0.035 | -118.849 | -11.818 | -68.693 | -1.889 | -370.307 | -1,106.762 | -16.017 | 0 | 0 | -6.09 | -2.269 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -2.088 | -0.944 | 18.358 | -1.639 | 19.266 | 34.114 | 15.403 | 8.223 | -61.924 | 45.381 | 15.134 | 5.302 | 4.883 | 7.501 | 41.72 | -4.071 | -5.36 | -10.163 | 17.305 | -5.56 | -11.392 | -11.186 | -9.691 | -9.515 | -9.662 | -8.853 |
| Net Income
| -73.456 | -35.216 | -168.148 | -176.999 | -157.899 | -176.846 | -155.973 | -148.416 | 59.365 | -246.711 | -147.177 | -155.935 | -96.348 | -163.079 | -119.981 | -115.859 | -121.034 | -91.85 | -73.458 | -59.98 | -65.895 | -61.185 | -38.641 | -31.401 | -26.551 | -34.156 |
| Net Income Ratio
| -33.882 | -0.167 | -96.36 | -43.265 | -96.221 | -96.849 | -83.408 | -439.101 | 0.805 | -145.638 | -11.421 | -66.525 | -1.783 | -352.985 | -983.451 | -14.256 | 0 | 0 | -5.316 | -2.243 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.39 | -0.2 | -0.96 | -1.08 | -0.98 | -1.16 | -1.04 | -1 | 0.4 | -1.69 | -1.01 | -1.06 | -0.66 | -1.18 | -1.01 | -0.98 | -1.03 | -0.78 | -0.62 | -0.51 | -0.71 | -0.51 | -0.42 | -0.34 | -0.29 | -0.37 |
| EPS Diluted
| -0.39 | -0.2 | -0.96 | -1.08 | -0.98 | -1.16 | -1.04 | -1 | 0.4 | -1.69 | -1.01 | -1.06 | -0.66 | -1.18 | -1.01 | -0.98 | -1.03 | -0.78 | -0.62 | -0.51 | -0.71 | -0.51 | -0.42 | -0.34 | -0.29 | -0.37 |
| EBITDA
| -171.074 | 5.339 | -169.229 | -157.692 | -134.941 | -117.609 | -112.889 | -113.707 | 27.698 | -156.44 | -137.148 | -149.684 | -91.235 | -159.979 | -124.063 | -119.238 | -125.46 | -100.072 | -81.111 | -58.411 | -72.418 | -66.139 | -64.28 | -40.845 | -35.455 | -42.397 |
| EBITDA Ratio
| -78.909 | 0.025 | -96.979 | -38.546 | -82.231 | -64.408 | -60.368 | -336.411 | 0.376 | -92.349 | -10.643 | -63.858 | -1.689 | -346.275 | -1,016.91 | -14.672 | 0 | 0 | -5.87 | -2.184 | 0 | 0 | 0 | 0 | 0 | 0 |